9 research outputs found
Manufacture and evaluation of 3-dimensional printed sizing tools for use during intraoperative breast brachytherapy
Get PDFAbstractThree-dimensional (3D) printing has emerged as a promising modality for the production of medical devices. Here we describe the design, production, and implementation of a series of sizing tools for use in an intraoperative breast brachytherapy program. These devices were produced using a commercially available low-cost 3D printer and software, and their implementation resulted in an immediate decrease in consumable costs without affecting the quality of care or the speed of delivery. This work illustrates the potential of 3D printing to revolutionize the field of medical devices, enabling physicians to rapidly develop and prototype novel tools
Gene expression signatures of breast cancer stem and progenitor cells do not exhibit features of Warburg metabolism
Get PDFEstrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations
Full text linkManufacture and evaluation of 3-dimensional printed sizing tools for use during intraoperative breast brachytherapy
No full textThree-dimensional (3D) printing has emerged as a promising modality for the production of medical devices. Here we describe the design, production, and implementation of a series of sizing tools for use in an intraoperative breast brachytherapy program. These devices were produced using a commercially available low-cost 3D printer and software, and their implementation resulted in an immediate decrease in consumable costs without affecting the quality of care or the speed of delivery. This work illustrates the potential of 3D printing to revolutionize the field of medical devices, enabling physicians to rapidly develop and prototype novel tools
A Declining Rate of Completion Axillary Dissection in Sentinel Lymph Node-positive Breast Cancer Patients Is Associated With the Use of a Multivariate Nomogram
No full textWhile standard care for sentinel lymph node positive breast cancer patients is to perform axillary dissection, for a low-risk subgroup this may not be required. Among 287 selected SLN-positive patients who did not have axillary dissection, we predicted a 9% rate of residual axillary metastases but observed axillary local recurrence in 2% at 23 months follow-up
Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy
No full textIntravenous and Isolated Limb Perfusion Delivery of Wild Type and a Tumor-Selective Replicating Mutant Vaccinia Virus in Nonhuman Primates
No full text
